Commentary by Cara Litvin MD, Executive Editor, Clinical Correlations
I frowned as my patient handed over some papers to me at a regularly scheduled follow-up clinic visit. For the second time in a row, he …
Commentary by Cara Litvin MD, Executive Editor, Clinical Correlations
I frowned as my patient handed over some papers to me at a regularly scheduled follow-up clinic visit. For the second time in a row, he …
A 46 year old male with a past medical history of hypertension presents to the emergency room complaining of constant throbbing epigastric pain for one day. He rates the pain as 7/10, with some radiation to his chest. He reports some mild nausea, but denies diarrhea or constipation. He does endorse a bloated sensation for the …
Commentary by Jacqueline Friedman, MD, Clinical Associate Professor of Neurology, Director, New York Region Veterans Administration Multiple Sclerosis Center of Excellence
Multiple sclerosis (MS), a chronic disease of the central nervous system, …
Commentary By: Neil Shapiro, M.D. Editor-in-Chief Clinical Correlations
As summer winds down and the weather prematurely cools off, this weeks shortcuts finds us focusing on the genetics of coumadin treatment, the very …
Commentary by Rosemary Adamson, PGY2, Deena Altman PGY-1 and Harold Horowitz, Professor of Medicine, Section of Infectious Diseases
Syphilis is back! You know the drill: an 80-something year old man presents with …
Case Presentation By: Marshall Fordyce, Senior Chief Resident
Welcome to the monthly posting of our NYU Department of Medicine’s Clinical Pathology Conference. Use the links below to review the case and …
Commentary by Helen Kourlas, PharmD
Beta-adrenergic receptor antagonists, commonly known as beta-blockers (B-blockers) have been used for decades to treat hypertension, ischemic heart disease and some arrhythmias – and more recently to …
Commentary By Sean Cavanaugh, M.D. Associate Editor, Clinical Correlations
With the ever-increasing public concern about drug safety, and the profusion of wave-making research into clinical endpoints, occasional very public collisions are inevitable. And so opens this week’s Shortcuts…
Two …